The Real Brokerage (REAX)
(Real Time Quote from BATS)
$5.69 USD
-0.04 (-0.70%)
Updated Jul 25, 2024 10:40 AM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for The Real Brokerage Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 689 | 382 | 122 | 17 | NA |
Cost Of Goods | 626 | 350 | 111 | 14 | NA |
Gross Profit | 63 | 32 | 11 | 2 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 89 | 52 | 22 | 5 | 0 |
Income After Depreciation & Amortization | -26 | -20 | -11 | -3 | 0 |
Non-Operating Income | -1 | 1 | 0 | -1 | NA |
Interest Expense | 1 | 1 | 1 | 0 | NA |
Pretax Income | -27 | -20 | -12 | -4 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -27 | -20 | -12 | -4 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -28 | -21 | -12 | -4 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -25 | -19 | -11 | -3 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -26 | -20 | -11 | -3 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 178.13 | 171.48 | 170.48 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.15 | -0.12 | -0.07 | NA | NA |
Diluted Net EPS (GAAP) | -0.15 | -0.12 | -0.07 | NA | NA |
Fiscal Year end for The Real Brokerage Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 200.74 | 181.34 | 214.64 | 185.33 |
Cost Of Goods | NA | 179.98 | 165.81 | 195.87 | 167.57 |
Gross Profit | NA | 20.76 | 15.53 | 18.77 | 17.76 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 36.48 | 26.82 | 22.74 | 21.50 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -15.72 | -11.29 | -3.97 | -3.74 |
Non-Operating Income | NA | 0.17 | -0.67 | 0.04 | 0.04 |
Interest Expense | NA | 0.55 | 0.03 | 0.01 | 0.27 |
Pretax Income | NA | -16.10 | -11.99 | -3.94 | -3.97 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | -0.03 | 0.09 | 0.15 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -16.10 | -11.99 | -3.94 | -3.97 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -16.10 | -11.96 | -4.02 | -4.12 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 184.69 | 182.45 | 180.61 | 179.76 |
Diluted EPS Before Non-Recurring Items | NA | -0.04 | -0.07 | -0.02 | -0.02 |
Diluted Net EPS (GAAP) | NA | -0.09 | -0.07 | -0.02 | -0.02 |